Healthcare -
Biotechnology - NYSE - US
$ 1.75
-4.37 %
$ 34.1 M
Market Cap
-0.41
P/E
ANVS - CHANGE IN WORKING CAPITAL
Change in Working Capital ANVS - Annovis Bio, Inc.
2.44 M
LAST VALUE
92.66%
2 YEAR CAGR
102.01%
5 YEAR CAGR
0.00%
10 YEAR CAGR